U.S. Food and Drug Administration
Protecting and Promoting Your Health
Small Business Assistance
Center for Drug Evaluation and Research
FDA eCTD Overview and Submission WBT
Transitioning to eCTD (From Paper or Non-eCTD Format)
MenuGlossaryHelpFAQsResourcesFDA/DRUGSCDERLearn
Resubmission of Materials
Get Adobe Flash player

The first question sponsors have when transitioning to eCTD format is, "Do I have to resubmit anything if I've begun the process in non-eCTD format?"

Resubmission of previously submitted information is generally unnecessary when converting to eCTD format.

FDA recommends that you contact the ESUB group at esub@fda.hhs.gov when converting to eCTD format for specific advice and help, prior to submitting an actual eCTD submission.

USER INSTRUCTIONS:
Select BACK to return to the question.
Page 7 of 8
Back Button
Next Button Disabled